ErbB2 overexpression on occult metastatic cells in bone marrow predicts poor clinical outcome of stage I-III breast cancer patients.

Source:http://linkedlifedata.com/resource/pubmed/id/11280743

Cancer Res. 2001 Mar 1 61 5 1890-5

Download in:

View as

Triples

General Info

PMID
11280743